002742.SZ · 冀衡医药
China A-shares · RS rating 58 · As of 2026-10-14
| Price | 3.93 CNY |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 58 / 19 / 80 / 47 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 17 / 23 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -30.4% |
| Distance from 52-week high | +37.0% |
| Market cap (USD) | $428.7M |